Qube Research & Technologies LTD Matinas Bio Pharma Holdings, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$0.5 - $1.06 $29,761 - $63,094	-59,523 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.92 - $1.22 $54,761 - $72,618	59,523 New	59,523 $60,000
Q2 2021 Aug 13, 2021	SELL	$0.75 - $1.1 $16,732 - $24,541	-22,310 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$0.96 - $1.74 $37,564 - $68,086	-39,130 Reduced 63.69%	22,310 $23,000
Q4 2020 Feb 16, 2021	BUY	$0.76 - $1.47 $46,694 - $90,316	61,440 New	61,440 $84,000

39M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $774M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.